These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4292621)

  • 1. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 2. Leurosine sulfate (NSC-90636) in treatment of Hodgkin's disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma.
    Mathe G; Schneider M; Bond P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Cancer Chemother Rep; 1965 Dec; 49():47-9. PubMed ID: 5322839
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial treatment of acute leukemia and Hodgkin's disease with rubidomycin (or daunomycin) alone or in combination].
    Mathé G; Amiel JL; Hayat M; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Ceoara B
    Sem Hop; 1967 Jul; 43(32):2108-14. PubMed ID: 4292321
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphoma.
    Takasugi BJ; Jones SE; Robertone AB
    Cancer Treat Rep; 1984 Nov; 68(11):1399-401. PubMed ID: 6498855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
    Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
    Invernizzi R
    Minerva Med; 1980 Nov; 71(44):3247-50. PubMed ID: 6935535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
    Cajozzo A; Citarrella P; Carreca I; D'Eredità F
    Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.
    Marmont AM; Damasio EE
    Blood; 1967 Jan; 29(1):1-21. PubMed ID: 5334796
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
    Mathé G; Misset JL; De Vassal F; Gouveia J; Hayat M; Machover D; Belpomme D; Pico JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; De Luca L
    Cancer Treat Rep; 1978 May; 62(5):805-9. PubMed ID: 274996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 12. AMSA therapy for children with lymphoblastic malignancy.
    Hutter JJ; Meyskens FL
    Cancer Treat Rep; 1982 Mar; 66(3):593-4. PubMed ID: 6949644
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of some infantile malignant neoplasms with Vinca rosea alkaloids].
    Nigro N; Madon E
    Cancro; 1968; 21():Suppl 6:119+. PubMed ID: 4313386
    [No Abstract]   [Full Text] [Related]  

  • 14. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
    Beck ID; Lemmel EM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527
    [No Abstract]   [Full Text] [Related]  

  • 15. [When to terminate the treatment of children with Hodgkin's disease, lymphoblastic leukemia and non-Hodgkin's lymphoma. Analysis of 80 cases].
    Armata J
    Pediatr Pol; 1979 Aug; 54(8):877-85. PubMed ID: 291888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endolymphatic use of drug preparations in the treatment of malignant tumors of the lymphatic system].
    Kuliev ShB
    Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):14-7. PubMed ID: 5394760
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
    Cheţa D; Micu D; Cheţa N
    Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modern aspects of treatment of acute leukemia].
    Lorie IuI; Streliukhina NV
    Vestn Akad Med Nauk SSSR; 1968; 23(4):21-5. PubMed ID: 5262437
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.